Immunomedics Seeks $14M as Bridge to Milestones
By Marie Powers
Monday, February 25, 2013
Immunomedics Inc. went small with its first financing in more than five years, pricing an underwritten public offering of 6.1 million shares at $2.30 each a 15 percent discount to Thursday's closing price and seeking to raise just $14 million.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.